| Recent advances in amorphous solid dispersions: preformulation, formulation strategies, technological advancements and characterization S Tambe, D Jain, SK Meruva, G Rongala, A Juluri, G Nihalani, HK Mamidi, ... Pharmaceutics 14 (10), 2203, 2022 | 44 | 2022 |
| Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders–Part I S Meruva, P Thool, S Shah, S Karki, W Bowen, I Ghosh, S Kumar International Journal of Pharmaceutics 568, 118189, 2019 | 32 | 2019 |
| Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing B Mitra, P Thool, S Meruva, JA Aycinena, J Li, J Patel, K Patel, A Agarwal, ... International Journal of Pharmaceutics 574, 118905, 2020 | 30 | 2020 |
| Polyethylene oxide (PEO) molecular weight effects on abuse-deterrent properties of matrix tablets S Meruva, MD Donovan AAPS PharmSciTech 21, 1-10, 2020 | 27 | 2020 |
| Effects of drug-polymer interactions on tablet properties during the development of abuse-deterrent dosage forms S Meruva, MD Donovan AAPS PharmSciTech 20, 1-12, 2019 | 20 | 2019 |
| Development of low dose micro-tablets by high shear wet granulation process S Gupta, P Thool, S Meruva, J Li, J Patel, A Agrawal, S Karki, W Bowen, ... International Journal of Pharmaceutics 587, 119571, 2020 | 19 | 2020 |
| Human volunteer, in vitro, and molecular level evaluation of an optimized taste-masked isoniazid-chitosan spray-dried microparticle matrix WC Stagner, M Iyer, V Rathod, S Meruva, S Staton, RV Haware International journal of pharmaceutics 572, 118774, 2019 | 16 | 2019 |
| Downstream processing of irbesartan nanocrystalline suspension and mini-tablet development–Part II S Meruva, P Thool, S Karki, W Bowen, I Ghosh, S Kumar International Journal of Pharmaceutics 568, 118509, 2019 | 13 | 2019 |
| Use of drug release testing to evaluate the retention of abuse-deterrent properties of polyethylene oxide matrix tablets S Meruva, L Rezaei, P Thool, MD Donovan AAPS PharmSciTech 21, 1-12, 2020 | 10 | 2020 |
| Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets S Meruva, P Thool, Y Gong, S Karki, W Bowen, S Kumar International Journal of Pharmaceutics 577, 119026, 2020 | 9 | 2020 |
| Effect of manufacturing process on the retention of abuse-deterrent properties of PEO-matrix tablets L Rezaei, S Meruva, MD Donovan AAPS PharmSciTech 23 (1), 38, 2021 | 6 | 2021 |
| A novel use of nanocrystalline suspensions to develop sub-microgram dose micro-tablets S Meruva, P Thool, Y Gong, A Agrawal, S Karki, W Bowen, B Mitra, ... Journal of Pharmaceutical Sciences 110 (9), 3276-3288, 2021 | 6 | 2021 |
| Dipalmitoylphosphatidylcholine (DPPC): annealing strategy to mitigate variability in thermotropic and moisture sorption behavior S Meruva, AB Singaraju, BK Gowdampally, BP Vinjamuri, WC Stagner Journal of Pharmaceutical Sciences 107 (10), 2635-2642, 2018 | 4 | 2018 |
| Current State of Minitablet Product Design: A Review S Meruva, AB Singaraju, BP Vinjamuri, R Ternik, WC Stagner Journal of Pharmaceutical Sciences, 2024 | | 2024 |
| Material Properties and Drug Release from Polyethylene Oxide Based Abuse-Deterrent Tablets S Meruva The University of Iowa, 2021 | | 2021 |
Prajwal ThoolGenentechVerified email at gene.com
